"Newman Regional Health provides award winning, state of the art healthcare 24 hours a day to patients of all ages in our primary service area which includes all of Lyon County and most of Chase, Coffey, Greenwood, Morris, Osage and Wabaunsee Counties in east central Kansas."

During the past decade, Newman Regional Health conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 23 clinical trials were completed, i.e. on average, 121.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 21 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Newman Regional Health" #1 sponsor was "SWOG Cancer Research Network" with 16 trials, followed by "National Cancer Institute (NCI)" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "NSABP Foundation Inc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Newman Regional Health" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Biologics, Inc." with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Newman Regional Health" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Cancer" (2 trials), "Breast Ductal Carcinoma In Situ" (2 trials) and "Recurrent Melanoma" (2 trials). Many other conditions were trialed in "Newman Regional Health" in a lesser frequency.

Most popular intervention types in "Newman Regional Health" are "Drug" (29 trials), "Other" (25 trials), "Biological" (13 trials), "Procedure" (5 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Docetaxel" (5 trials), "Placebo Administration" (5 trials), "Quality-of-Life Assessment" (5 trials) and "Clinical Observation" (4 trials). Other intervention names were less common.

The vast majority of trials in "Newman Regional Health" are 30 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Newman Regional Health". undefined are not yet recruiting, 3 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Newman Regional Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Newman Regional Health, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".